OBN BioTuesday: A Spotlight on Oncology Precision Prevention Treatments and the Expected Impact on People with High-Risk Conditions
Tuesday, 02 July 2024, 5pm to 8pm
BioEscalator, University of Oxford, Innovation Building, Old Road Campus, Roosevelt Drive, Oxford, OX3 7FZ
Join us for an exciting evening of insights and discussions featuring experts from Big Pharma, Small Pharma, Regulatory, and Patient communities.
About the event
Speakers on the night will share insight on the new era of cancer prevention trials. Research and clinical trials in cancer prevention are critical for improving patient outcomes and reducing pressure on healthcare systems. The new field of precision prevention exploits biological insights into risk factors and cancer development to precisely target interventions to individuals at high risk, with the aim of delaying or preventing cancer. Oxford University hosts the UK's first and only Cancer Research UK-accredited trials centre specialising in cancer precision prevention studies and is changing the way that these trials are run. Compared to traditional cancer prevention trials, precision prevention trials are more focused, smaller and shorter, and thus more attractive to commercial timelines. This event will highlight the innovations in cancer prevention trials and explore the impact on pharma and people affected by a high-risk condition.
See the programme and register
This event has been made possible by the collaborative efforts of:
Organiser
Event hosts
